English | 中文版 | 手机版 企业登录 | 个人登录 | 邮件订阅
生物器材网 logo
HD5000AI多谱超分辨菌落成像系统
当前位置 > 首页 > 行业资讯 > 展会 > 疫苗中国2011-疫苗发展高峰会议将在上海隆重召开

疫苗中国2011-疫苗发展高峰会议将在上海隆重召开

浏览次数:3197 发布日期:2011-10-11  来源:本站 本站原创,转载请注明出处

SHANGHAI, Oct. 9, 2011 /PRNewswire-Asia/ -- Vaccines made in China will now be supplied through United Nations (UN) agencies to developing countries, after recognition from the World Health Organisation (WHO) that China's State Food and Drug Administration (SFDA) has complied with international standards for vaccine regulation. The acknowledgement on China's regulatory system is a precondition that could lead to the UN purchasing individual vaccines from Chinese vaccine makers. For this to occur, the manufacturers also have to pass the approval for China's new version of GMP (Good Manufacturing Practice) for the Chinese pharmaceutical industry that was released at the end of February. On the other hand, China's vaccine industry is driven by novel technologies, especially by recent technological advances in vaccine research, production and distribution.

Organized by Global Leaders Institute, more than 300 of the world's vaccine business leaders, researchers, policy makers, and advocates will be in Shanghai this November 29 and 30 attending VacChina 2011, the only international meeting in China devoted to vaccine development opportunity in China. The objective of this conference is to provide communication, education and networking opportunities for business leaders and scientists engaged in vaccine development whether in academia, biotech or industry.

This year's anniversary conference features a workshop on Vaccine Manufacturing and WHO pre-qualification. The workshop will focus on the technologies and challenges of vaccine manufacturing in today's marketplace including quality, safety, policy, and examples from the industry. Besides, VacChina 2011 provides a comprehensive, in-depth analysis of China's vaccine market, new vaccine targets and methods of delivery, regulatory and funding initiatives, as well as following issues:

  • WHO pre-qualification requirements and details
  • Updates on cGMP and related policies
  • Future trends in vaccine discovery & new vaccines
  • Human vaccines focusing on infectious diseases, bacterial & viral
  • Single use applications in vaccine process development
  • Advances in technology for the purification and manufacturing of vaccines
  • The development of therapeutic vaccines
  • The commercial & business development of novel adjuvant vaccines

For further information and the opportunity to register online please visit: vac.globaleaders.com

Or contact Daniel Chen via e-mail daniel.chen@globaleaders.com or call at 8621-32516046

About Global Leaders Institute

Global Leaders Institute (GLI) is the producer and organizer of top-level business events. We focus on the development and operation of the strategic, market leading business conference. We focus on the specialty spirit and professional attainment. We focus on value creation for our client. We provide 60 annual conferences across energy, finance, transportation, life science, real estate, telecom and media, etc. each year.

相关链接:
疫苗中国2011诚邀世界级生物技术人士及制药公司参与
疫苗中国2011-疫苗发展高峰会议(11月29-30日,上海)



高端的生物技术和制药加工设备
用户名: 密码: 匿名 快速注册 忘记密码
评论只代表网友观点,不代表本站观点。 请输入验证码: 8795
Copyright(C) 1998-2026 生物器材网 电话:021-64166852;13621656896 E-mail:info@bio-equip.com